Skip to main content

Table 1 Clinical characteristics of the study cohort at baseline

From: A prospective clinical trial of specialist renal nursing in the primary care setting to prevent progression of chronic kidney: a quality improvement report

Variable   
Number N 52
Practice A 28 (54)
  B 24 (46)
Age Years 57.5 (47–64)
Gender Male 25 (48)
  Female 27 (52)
Ethnicity New Zealand European 5 (10)
  Cook Island Maori/Samoan 10 (19)
  New Zealand Maori 37 (71)
Appropriate secondary specialist care   15 (29)
Total chronic medical illness burden CIRS Score 6.92 (2.27)
2 or more diagnoses (CIRS domains) % 33
3 or more diagnoses (CIRS domains) % 3
4 or more diagnoses (CIRS domains) % 0
Albumin to creatinine ratio mg/mmol 34.9 (14.2-150.9)
5-year absolute cardiovascular risk % 20 (15–27)
Estimated GFR mL/min/1.73 m2 63 (48–77)
Systolic BP mmHg 150 (144.5-160)
Diastolic BP mmHg 90 (80–110)
Serum total cholesterol mmol/L 5.25 (4.1-6)
Glycosylated haemoglobin % 8.8 (7.7-10.7)
Body mass index kg/m2 37 (32.5-43.5)
Active smoking   18 (35)
Self-management Score  
Overall score (scale 0 to 104)   82 (72–91)
Knowledge of medications (scale 0 to 8)   6 (5–8)
Knowledge of condition (scale 0 to 8)   6 (4–7)
Medication adherence (scale 0 to 8)   8 (5–8)
Healthy lifestyle (scale 0 to 8)   6 (4–8)
Prescribed aspirin % 31 (60)
Prescribed ACEi / ARBs % 45 (87)
Prescribed HMG-CoA reductase inhibitors % 32 (62)
Number of prescribed anti-hypertensives n 2 (1–3)
  1. All data are presented as n (%) or median (IQR).